Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

Randomised controlled trials and other prospective clinical studies for novel medical interventions in people with diabetes have traditionally reported HbA as the measure of average blood glucose levels for the 3 months preceding the HbA test date. The use of this measure highlights the long-establi...

Celý popis

Podrobná bibliografie

Vydáno v:	The lancet. Diabetes & endocrinology Ročník 11; číslo 1; s. 42
Hlavní autoři:	Battelino, Tadej, Alexander, Charles M, Amiel, Stephanie A, Arreaza-Rubin, Guillermo, Beck, Roy W, Bergenstal, Richard M, Buckingham, Bruce A, Carroll, James, Ceriello, Antonio, Chow, Elaine, Choudhary, Pratik, Close, Kelly, Danne, Thomas, Dutta, Sanjoy, Gabbay, Robert, Garg, Satish, Heverly, Julie, Hirsch, Irl B, Kader, Tina, Kenney, Julia, Kovatchev, Boris, Laffel, Lori, Maahs, David, Mathieu, Chantal, Mauricio, Dídac, Nimri, Revital, Nishimura, Rimei, Scharf, Mauro, Del Prato, Stefano, Renard, Eric, Rosenstock, Julio, Saboo, Banshi, Ueki, Kohjiro, Umpierrez, Guillermo E, Weinzimer, Stuart A, Phillip, Moshe
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 01.01.2023
Témata:	Adolescent Blood Glucose - analysis Blood Glucose Self-Monitoring Child Clinical Trials as Topic Diabetes Mellitus, Type 1 - drug therapy Humans Hyperglycemia - therapy Hypoglycemia - prevention & control Prospective Studies
ISSN:	2213-8595, 2213-8595
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!